Crossmark

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality

Crossref DOI link: https://doi.org/10.1186/s13613-021-00836-2

Published Online: 2021-03-22

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lim, Adeline http://orcid.org/0000-0001-6516-8435
Radujkovic, Aleksandar

Weigand, Markus A.

Merle, Uta
Funding

Funding for this research was provided by:

Universitätsklinikum Heidelberg
License Information

Text and Data Mining valid from 2021-03-22

Version of Record valid from 2021-03-22
More Information

Article History

Received: 2 December 2020

Accepted: 8 March 2021

First Online: 22 March 2021

Declarations

:

: Data analysis was approved (Number S-148/2020, S-546/2020) by the Ethics Committee of the Medical Faculty of Heidelberg University Hospital and was conducted in accordance with the Declaration of Helsinki [CitationRef removed].

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below